Cancer can be heart-breaking for families and it is vital we provide the best possible treatment. The Secretary of State for Health has signed a memorandum of understanding with BioNTech SE, to bring innovative vaccine research to England with the potential to transform outcomes for cancer patients.
The collaboration will aim to deliver 10,000 personalised therapies to UK patients by 2030 through a new research and development hub creating jobs and strengthening the UK’s position as a leader in global life sciences.
BionTech SE has a proven and distinguished record in vaccine technology and this partnership could mean saving lives with new cancer therapies.
Michael Tomlinson said
"Getting a diagnosis of cancer is extremely worrying and scary. This partnership represents great strides towards better outcomes for patients, and reflects how well the National Health Service, academia, the regulator and the private sector can work together."
Read more:
